Skip to main content
Terug
Watch Compare

NANOVIRICIDES, INC.

Datakwaliteit: 83%
NNVC
NYSE Manufacturing Chemicals
€ 0,98
▼ € 0,08 (-7,26%)
Marktkapitalisatie: 22,89 M
Prijs
€ 1,06
Marktkapitalisatie
22,89 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -7,43 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-91,18%
Onder sectorgemiddelde (-53,47%)
ROIC-72,69%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio4,43
Interest Coverage-168,54

Waardering

PE (TTM)
-2,75
Onder sectorgemiddelde (-1,48)
P/B Ratio2,07
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,8 -1,5
P/B 2,1 1,6
ROE % -91,2 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

2 analisten
Hold
Huidig
€ 0,98
+561.2%
Koersdoel
€ 6,50
€ 6,00
€ 6,50
€ 7,00
Vooruitzicht
Forward K/W -2,81
Forward WPA -€ 0,35
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,35
-€ 0,35 – -€ 0,35
 0,0 1
FY2026 -€ 0,35
-€ 0,35 – -€ 0,35
 0,0 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,08 -€ 0,11 -37,5%
Q32025 -€ 0,18 -€ 0,10 +44,4%
2026-Q2 -€ 0,08 -€ 0,12 -50,0%
2026-Q1 -€ 0,08 -€ 0,10 -25,0%

ETFs Holding This Stock

BRSIX BRSIX
0,05% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8,32 M
ROE -91,18% ROA -80,66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -7,43 M
ROIC -72,69% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,43
Interest Coverage -168,54 Asset Turnover N/A
Working Capital 4,10 M Tangible Book Value 10,76 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,75 Forward P/E N/A
P/B Ratio 2,07 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32,46%
Market Cap 22,89 M Enterprise Value 17,74 M
Per Share
EPS (Diluted TTM) -0,49 Revenue / Share N/A
FCF / Share -0,34 OCF / Share -0,34
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89,33%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -9,47 M -8,29 M -8,59 M -8,11 M -8,82 M
EPS (Diluted) -0,63 -0,70 -0,74 -0,70 —
Gross Profit — — — — —
Operating Income -9,59 M -8,52 M -8,94 M -8,11 M -8,74 M
EBITDA — — — — —
R&D Expenses 5,55 M 5,44 M 6,39 M 5,78 M 6,11 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 49.808,0 49.808,0 938,0 5.123,0 85.405,0
Income Tax — — — — 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,82 M 12,82 M 16,90 M 23,49 M 30,26 M
Total Liabilities 1,30 M 1,36 M 2,03 M — —
Shareholders' Equity 7,52 M 11,46 M 14,87 M 23,08 M 29,91 M
Total Debt — — — — —
Cash & Equivalents 1,56 M 4,80 M 8,15 M 14,07 M 20,52 M
Current Assets 1,67 M 4,97 M 8,45 M 14,42 M 20,82 M
Current Liabilities 1,31 M 1,36 M 534.250,0 412.837,0 351.146,0